Anixa Biosciences Inc Sustainability Reports
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines to address critical unmet needs in oncology. Its programs include developing a breast cancer vaccine, an ovarian cancer vaccine, and CAR-T immunotherapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300PW2C2QTAJL2D19
FIGI: BBG001S5Q1P7
7 reports from 2017 to 2025
